↓ Skip to main content

Dove Medical Press

The miR-200 family: multiple effects on gliomas

Overview of attention for article published in Cancer Management and Research, July 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Readers on

mendeley
14 Mendeley
Title
The miR-200 family: multiple effects on gliomas
Published in
Cancer Management and Research, July 2018
DOI 10.2147/cmar.s160945
Pubmed ID
Authors

Lilei Peng, Jie Fu, Yang Ming

Abstract

Gliomas are the most common type of primary brain tumors. MicroRNAs (miRNAs) are small noncoding RNAs that can epigenetically regulate target gene expression. The microRNA 200 family includes miR-200a, 200b, 200c, 141 and 429. Numerous studies have indicated that members of the miR-200 family play an important role in glioma development and metastasis. In this review, we summarize the data from various studies and highlight the effects of miR-200 on glioma metastasis, therapeutic response and prognosis.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 4 29%
Student > Bachelor 2 14%
Researcher 2 14%
Student > Ph. D. Student 2 14%
Other 1 7%
Other 2 14%
Unknown 1 7%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 57%
Medicine and Dentistry 3 21%
Neuroscience 2 14%
Unknown 1 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2021.
All research outputs
#6,922,550
of 22,699,621 outputs
Outputs from Cancer Management and Research
#286
of 1,988 outputs
Outputs of similar age
#120,528
of 326,977 outputs
Outputs of similar age from Cancer Management and Research
#12
of 73 outputs
Altmetric has tracked 22,699,621 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,988 research outputs from this source. They receive a mean Attention Score of 2.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,977 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.